Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has 6 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 140,000 shares. Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Press ... Dec 12, 2019 · AUPH Aurinia Pharmaceuticals Inc Ordinary Shares. Data is currently not available. DATA AS OF Feb 06, 2020. $19.83 0.11 0.56%. AUPH Aurinia … AUPH News Today (Aurinia Pharmaceuticals) | MarketBeat What's going on at Aurinia Pharmaceuticals (NASDAQ:AUPH)? View breaking news headlines for AUPH stock from trusted media outlets at MarketBeat. What's going on at Aurinia Pharmaceuticals (NASDAQ:AUPH)? View breaking news headlines for AUPH stock from trusted media outlets at MarketBeat. Share on Stocktwits. Print this article. Share by
5 Dec 2019 Sina Weibo SiteJot Skype Slashdot SMS StockTwits Svejo Symbaloo Bookmarks Threema Trello Tuenti Twiddla TypePad Post Viadeo Viber
Oct 10, 2010 · Stocktwits is a free app that offers an optional subscription and purchase product. About the Stocktwits Plus Monthly Subscription, Plus Yearly Subscription, and Lifetime Membership. Payment will be charged to your Apple ID account at the confirmation of purchase. Investor Relations :: Aurinia Pharmaceuticals Inc. (AUPH) Aurinia Pharmaceuticals Inc. Nasdaq: AUPH Symbol. Price. Change. Volume. Day Range. 52 Wk Range. Company Overview. Aurinia is a late clinical-stage biopharmaceutical company focused on developing and commercializing therapies to change the treatment paradigm for patients impacted by rare autoimmune and inflammatory conditions. Aurinia is AUPH Price Target and Analyst Ratings (Aurinia ...
7 Sep 2017 Social media sites such as Twitter, Investors Hub, and StockTwits have lately Former AUPH CEO, Stephen Zaruby explains that the company
Shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) were up 14% at 3:35 p.m. EST on Tuesday as investors anticipated the release of clinical trial data for the biotech's lead drug voclosporin. Discussion Page for Aurinia Pharmaceuticals ($AUPH)
AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
AUPH - POSITIVE Phase 3 data; $167.7 Million offering at ... Yep, been with the Auphians since we broke away from iHub. That app has some straight up mentally handicapped posters. There is a decent group that posts on stocktwits including the guys that started the auphians blogspot. A few of them went through the Ariad deal so I have some faith in their views on AUPH. This stock is going to fluctuate. AUPH | Aurinia Pharmaceuticals Inc. Insider Actions ... Nov 06, 2019 · Aurinia Pharmaceuticals Inc. insider activity by MarketWatch. View the latest news on AUPH company insiders for best stock investing positioning. AUPH Chart
Oct 21, 2019 · Complete response rates in the AURA trial when viewed in the proper context are in-line with those achieved by other calcineurin inhibitors (CNIs) alone and using multi-targeted therapy (MTT).
Aurinia Pharmaceuticals (AUPH) Stock: Up On Buyout Hopes ... At the moment, investors in Aurinia Pharmaceuticals seem to be voicing the same opinions on both Twitter and StockTwits. Ultimately, they’re looking at the stock as a strong takeover target. AUPH / Aurinia Pharmaceuticals Inc - Institutional ... Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has 6 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 140,000 shares. Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Press ... Dec 12, 2019 · AUPH Aurinia Pharmaceuticals Inc Ordinary Shares. Data is currently not available. DATA AS OF Feb 06, 2020. $19.83 0.11 0.56%. AUPH Aurinia … AUPH News Today (Aurinia Pharmaceuticals) | MarketBeat